In a recent decision, the Centers for Medicare and Medicaid Services have declined a proposal to expand Medicare coverage for ...
The Centers for Medicare and Medicaid Services said late Friday that it would not cover the medications under Medicare’s Part ...
CMS ends Biden-era proposal to expand Medicare coverage of anti-obesity drugs. Seniors continue paying out of pocket for ...
The Centers for Medicare and Medicaid Services said late Friday that it would not cover medications such as Wegovy that are ...
President Donald Trump’s team is rejecting former President Biden's plan to cover weight loss drugs like Wegovy and Zepbound for older Americans through Medicare. The Centers for Medicare and Medicaid ...
Administration officials reversed a decision made during the Biden presidency that would have given millions of people access ...
The Trump administration has chosen not to finalize a rule proposed by the Biden administration that would have allowed ...
The Centers for Medicare and Medicaid Services (CMS) announced Friday it will not be finalizing a rule proposed by the Biden ...
Trump administration rejects a Biden plan to expand Medicare coverage of weight-loss drugs such as Zepbound and Wegovy.
The Biden administration proposal would have significantly expanded access to obesity to millions of Americans but would have cost the government billions.